Extracorporeal CO2 Removal Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Extracorporeal CO2 Removal Devices Market is Segmented by Product (Extracorporeal CO2 Devices, Disposables, and Others), Application (Chronic Obstructive Pulmonary Disease (COPD), Acute Respiratory Distress Syndrome (ARDS), Bridge to Lung Transplant, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The report offers the value (in USD million) for the above segments.

Extracorporeal CO2 Removal Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Extracorporeal CO2 Removal Devices Industry Overview

The extracorporeal Co2 removal devices market is moderately competitive due to the presence of several major players. The companies are adopting various key strategies such as collaborations, partnerships, agreements, and new product launches to retain their position in the market. Some of the key companies in the market include Medtronic, Getinge AB, Xenios AG, Alung Technologies, and ESTOR SpA.

Extracorporeal CO2 Removal Devices Market Leaders

  1. Medtronic

  2. Getinge AB

  3. Xenios AG

  4. Alung Technologies

  5. ESTOR S.P.A

  6. *Disclaimer: Major Players sorted in no particular order
Extracorporeal CO2 Removal Devices Market Concentration

Extracorporeal CO2 Removal Devices Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?